This Week's CGT News: World's First Solid Tumor CAR T Approved in China
06/30/2026
5 min read
News
False
Advertisement
Related Content
Cell & Gene
Industry News
Research News
This Week’s CGT News: Antifreeze Sugars Protect CAR T Cells
August 24, 2026
5 min read
A new preservation method could remove a major barrier to treatment, the FDA approves the first gene therapy for GSDIa, and ultrasound directs CAR T cells toward solid tumors
Cell & Gene
Industry News
Research News
This Week’s CGT News: T-Cell Therapy Clears Pediatric Solid Tumor
August 17, 2026
3 min read
PRAME-targeted T cells produce a complete response in metastatic nephroblastoma, CAR T cells remain active after a decade, and an in vivo CRISPR screen identifies edits that strengthen solid-tumor activity
Cell & Gene
Industry News
Research News
This Week’s CGT News: In Vivo CAR T Draws Major Investment
August 10, 2026
3 min read
Johnson & Johnson partners with Sail Biomedicines, an FDA advisory committee votes against deramiocel for Duchenne cardiomyopathy, and researchers uncover factors influencing CAR T and CAR NK outcomes
Cell & Gene
Industry News
Technology & Manufacturing
Inside VIVEbiotech’s Work with Zelluna on TCR-NK Cell Therapy
July 14, 2026
3 min read
VIVEbiotech CEO Jon Alberdi lifts the lid on an eight-year collaboration focused on GMP lentiviral vectors for off-the-shelf solid tumor therapies